Cysteinyl‐leukotrienes induce vascular endothelial growth factor production in human monocytes and bronchial smooth muscle cells
- 1 December 2010
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 41 (2) , 204-217
Abstract
Cite this as: S. Poulin, C. Thompson,M. Thivierge, S. V'eronneau,S. McMahon, C. M. Dubois, J. Stankova and M. Rola‐Pleszczynski, Clinical & Experimental Allergy, 2011 (41) 204–217.Summary: Background Cysteinyl leukotrienes (cysLTs) are suggested to be implicated in the process of airway remodelling in asthma.Objective We investigated the potential for cysLTs to modulate vascular endothelial growth factor (VEGF) expression, a growth factor involved in the angiogenesis of airway remodelling.Methods VEGF mRNA and protein were quantified by real‐time PCR and ELISA, respectively. VEGF promoter activation was assessed using luciferase gene‐tagged promoter constructs.Results We found that LTD4 induction of VEGF in human monocytes and bronchial smooth muscle cells is cysLT1 dependent. Stimulation of HEK293 cells stably expressing cysLT1 or cysLT2 with cysLTs showed a concentration‐dependent activation of the VEGF promoter and a time‐dependent increase in VEGF mRNA and protein. For the cysLT1‐mediated response, mutations of hypoxia‐induced factor‐1 (HIF‐1) sites failed to reduce cysLT‐induced VEGF promoter activation and 5′ deletions showed that the proximal region containing one AP‐1 and four specificity protein 1 (Sp1) sites was necessary. Pretreatment with inhibitors of c‐Jun N‐terminal kinase (JNK) and extracellular signal‐regulated kinase (ERK), but not p38, and an overexpression of dominant negative forms of c‐Jun, c‐Fos or Ras suggested the implication of mitogen‐activated protein kinases and AP‐1. Mutation of the AP‐1‐binding element failed to prevent VEGF transactivation suggesting that AP‐1 might not act directly on the promoter. Moreover, inhibition of Sp1‐dependent transcription by mithramycin completely inhibited VEGF promoter transactivation and VEGF mRNA expression by LTD4. Finally, mutations of Sp1 binding elements prevented VEGF promoter transactivation.Conclusion and Clinical Relevance Our data indicate for the first time that cysLTs can transcriptionally activate VEGF production via cysLT1 receptors, with the involvement of JNK, ERK, the AP‐1 complex and Sp1. These findings suggest that cysLTs may be important in the angiogenic process of airway remodelling and potentially provide a previously unknown benefit of using cysLT1 receptor antagonists in the prevention or treatment of airway remodelling in asthma.Keywords
This publication has 50 references indexed in Scilit:
- Sp-1 and c-Myc Mediate Lysophosphatidic Acid–Induced Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Cells via a Hypoxia-Inducible Factor-1–Independent MechanismClinical Cancer Research, 2009
- Airway modeling and remodeling in the pathogenesis of asthmaCurrent Opinion in Allergy and Clinical Immunology, 2008
- Leukotriene D4‐induced, epithelial cell‐derived transforming growth factor β1 in human bronchial smooth muscle cell proliferationClinical & Experimental Allergy, 2007
- Differential regulation and properties of MAPKsOncogene, 2007
- The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptorThe EMBO Journal, 2006
- Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expressionJournal of Allergy and Clinical Immunology, 2004
- Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitationThorax, 2004
- Induction of Hypoxia-Inducible-Factor 1 by Nitric Oxide Is Mediated via the PI 3K PathwayBiochemical and Biophysical Research Communications, 2000
- LEUKOTRIENES, LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMA: AN UPDATE. PART II: CLINICAL STUDIES WITH LEUKOTRIENE RECEPTOR ANTAGONISTS AND LEUKOTRIENE SYNTHESIS INHIBITORS IN ASTHMAPharmacological Research, 1999
- Leukotriene C4 stimulates angiogenesis in bovine carotid artery endothelial cells in vitroBiochemical and Biophysical Research Communications, 1989